NCT04652609 Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program
| NCT ID | NCT04652609 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Granada |
| Condition | Breast Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2021-01-01 |
| Primary Completion | 2025-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2021-01-01 with a primary completion date of 2025-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * HER2+ breast cancer diagnosis * On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy) Exclusion Criteria: * Previous diagnosis of cancer * Pregnant * Cardiac pathology * No symptoms or pathology that could be confused with neuropathy or related to diabetes * No recommendation from oncologist for therapeutic exercise practice
Contact & Investigator
Irene Cantarero-Villanueva, PhD
PRINCIPAL INVESTIGATOR
Physical Therapy Deparment, Faculty of Health Sciences, University of Granada
Frequently Asked Questions
Who can join the NCT04652609 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 70 Years, studying Breast Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04652609 currently recruiting?
Yes, NCT04652609 is actively recruiting participants. Contact the research team at irenecantarero@ugr.es for enrollment information.
Where is the NCT04652609 trial being conducted?
This trial is being conducted at Granada, Spain.
Who is sponsoring the NCT04652609 clinical trial?
NCT04652609 is sponsored by Universidad de Granada. The principal investigator is Irene Cantarero-Villanueva, PhD at Physical Therapy Deparment, Faculty of Health Sciences, University of Granada. The trial plans to enroll 25 participants.